Global Artificial Heart Lung Machines Revenue Is Nearly 240 Million USD
Thursday, 08 Nov, 2018
In the last several years, global market of Artificial Heart Lung Machines developed smoothly, with an average growth rate of 4.9 %. In 2016, global revenue of Artificial Heart Lung Machines is nearly 240 million USD; the actual production is about 950 units.

The classification of artificial heart lung machines includes single roller pump HLM and double roller pump HLM, and the revenue proportion of single roller pump HLM in 2016 is about 66.3%. Artificial heart lung machines can be used for cardiac surgery, lung transplant operation, acute respiratory failure treatment and other. The most proportion of artificial heart lung machines is used for cardiac surgery, and the sales proportion is about 66.2% in 2016.

North America is the largest sales place, with a sales market share nearly 36.4% in 2016. Following North America, Europe is the second largest sales place with the sales market share of 33.3%. China, Japan and Korea are also important sales regions for artificial heart lung machines.

Heart Lung Machine market is mainly occupied by large companies, Sorin as the largest player in the market produced over 57% of Artificial Heart Lung Machine and made more than 59.6% of revenue share in 2016. MAQUET followed as second produced about 18.3% in 2016.

Through the above research we tend to believe that Sorin is the most important player in the market and it will occupy a major share of the market in the future. The competition will become more intense, companies will play more and more attention to developing regions in the future.